HIV related bronchiectasis.

Holmes, Ann; Pelton, Steven I.; Steinbach, Suzanne; Luzzi, Graz

doi:10.1136/thx.50.11.1227

Cited by 16 publications

(4 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…With the application of antibiotics, genetic diseases such as cystic fibrosis of the lung, immunodeficiency disease and disorders of cilia movement were becoming the general causes of bronchiectasis [ 41 ]. NTM infections and α 1 -antitrypsin deficiency syndrome were all predisposing factors [ 42 ] which led to bronchiectasis becoming one of the potential factors in AIDS.…”

Section: Discussionmentioning

confidence: 99%

Systematic review/Meta-analysis Prevalence of nontuberculous mycobacteria in patients with bronchiectasis: a meta-analysis

Chu¹,

Zhao²,

Xiao³

et al. 2014

aoms

View full text Add to dashboard Cite

IntroductionNontuberculous mycobacteria (NTM) have emerged as critical opportunistic pathogens of lung diseases recently. Patients with preexisting bronchiectasis are susceptible to NTM. Nevertheless, patients with preexisting bronchiectasis are susceptible to NTM but the prevalence of NTM pulmonary infection in different species and geographical areas is still not fully understood.Material and methodsThe relevant data of the prevalence of NTM in patients with bronchiectasis were retrieved by searching the main databases such as PubMed, MEDLINE, Cochrane Library, and EMBASE. This meta-analysis was performed using Rev. Man 5.1 and Stata 11.0 software. The collected information of NTM prevalence was chosen as the effect size.ResultsThe results of the meta-analysis showed that the overall prevalence of NTM was 9.3% in patients with bronchiectasis. The further stratification of subgroup analysis indicated that the combined prevalence of NTM was higher in studies whose “sample size” was more than or equal to 100 (p = 0.002), in studies in which “time of study” was after or equal to 2002 (p < 0.001), in studies in which “participants’ geographic location” was Asian (p < 0.001) and in studies whose “method of study” was retrospective (p = 0.002) as well, compared with corresponding groups.ConclusionsOur findings suggested that the prevalence NTM infection is high in patients with bronchiectasis. A larger number of definitive randomized trials are still required to assess this research issue.

show abstract

Section: Discussionmentioning

confidence: 99%

Systematic review/Meta-analysis Prevalence of nontuberculous mycobacteria in patients with bronchiectasis: a meta-analysis

Chu¹,

Zhao²,

Xiao³

et al. 2014

aoms

View full text Add to dashboard Cite

show abstract

“… 10 Moreover, several studies have shown a higher-than-expected rate of bronchiectasis in persons living with HIV. 11 – 13 The association is not surprising as recurrent and/or severe airway infections are risk factors for the development of bronchiectasis, and even otherwise healthy individuals living with HIV have much higher rates of acute bronchitis and bacterial pneumonia than the general population.…”

Section: Part 1: Hiv-associated Airway Diseasesmentioning

confidence: 99%

Noninfectious Pulmonary Complications of Human Immunodeficiency Virus Infection

Staitieh

Guidot

2014

The American Journal of the Medical Sciences

View full text Add to dashboard Cite

Abstract:Human immunodeficiency virus type 1 (HIV-1) is the retrovirus responsible for the development of AIDS. Its profound impact on the immune system leaves the host vulnerable to a wide range of opportunistic infections not seen in individuals with a competent immune system. Pulmonary infections dominated the presentations in the early years of the epidemic, and infectious and noninfectious lung diseases remain the leading causes of morbidity and mortality in persons living with HIV despite the development of effective antiretroviral therapy. In addition to the long known immunosuppression and infection risks, it is becoming increasingly recognized that HIV promotes the risk of noninfectious pulmonary diseases through a number of different mechanisms, including direct tissue toxicity by HIV-related viral proteins and the secondary effects of coinfections. Diseases of the airways, lung parenchyma and the pulmonary vasculature, as well as pulmonary malignancies, are either more frequent in persons living with HIV or have atypical presentations. As the pulmonary infectious complications of HIV are generally well known and have been reviewed extensively, this review will focus on the breadth of noninfectious pulmonary diseases that occur in HIV-infected individuals as these may be more difficult to recognize by general medical physicians and subspecialists caring for this large and uniquely vulnerable population.

show abstract

“…9 Out of the very few studies reporting cases of bronchiectasis in HIV infected individuals, the prevalence ranged from 15 to 42%. [10][11][12][13][14][15][16] )ROORZLQJ WKH ¿UVW FDVH UHSRUW IURP 2[IRUG LQ 1992, 10 there are very few cases of HIV reported to have bronchiectasis although the prevalence of bronchiectasis is higher in HIV infected population. This might be because of the low index of suspicion and because of the fact that the easily available investigations like chest radiographs in WKH HDUO\ VWDJHV PD\ EH QRUPDO RU QRQVSHFL¿F Here we are reporting the case of bronchiectasis in HIV infected 7 years old child.…”

Section: Introductionmentioning

confidence: 99%

Bronchiectasis in a positive HIV child: a case report

Shrestha¹,

Kanskar²

2013

Journal of Institute of Medicine

View full text Add to dashboard Cite

+XPDQ LPPXQRGH¿FLHQF\ YLUXV +,9 LQIHFWLRQ KDV D ZLGH VSHFWUXP RI SXOPRQDU\ GLVHDVH ZKLFK XVXDOO\ FRPSOLFDWHV WKH FOLQLFDO FRXUVH 1RQ F\VWLF ¿EURVLV EURQFKLHFWDVLV LV PRUH FRPPRQ LQ children with HIV infection than in general population. Bronchiectasis in children with HIV if not diagnosed early and managed aggressively can lead to irreversible destruction of bronchial ZDOO DQG VXUURXQGLQJ WLVVXH OHDGLQJ WR VLJQL¿FDQW PRUELGLW\ 7KLV PLJKW GHFUHDVH WKH EHQH¿W RI the antiretroviral therapy (ARV) treatment on the long run.

show abstract

HIV related bronchiectasis.

Cited by 16 publications

References 4 publications

Systematic review/Meta-analysis Prevalence of nontuberculous mycobacteria in patients with bronchiectasis: a meta-analysis

Systematic review/Meta-analysis Prevalence of nontuberculous mycobacteria in patients with bronchiectasis: a meta-analysis

Noninfectious Pulmonary Complications of Human Immunodeficiency Virus Infection

Bronchiectasis in a positive HIV child: a case report

Contact Info

Product

Resources

About